The table below shows OCULAR THERAPEUTIX, INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
$1.33M
$1.77M
$1.94M
$1.26M
$1.56M
$1.51M
Gross profit
-
-
-
-
-
-
R&D
$66.21M
$52.36M
$51.08M
$42.86M
$37.05M
$28.86M
SG&A
OCUL annual revenue (10-K history)
OCULAR THERAPEUTIX, INC reported annual revenue of $51.95M for fiscal year 2025. That is down 18.5% from $63.72M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.89M (FY 2016) to $51.95M. Figures come from the company's audited annual reports as filed with the SEC.